Abstract: International cooperation has long been founded on the idea that securing a common factual understanding of things in the world is a prerequisite for deciding how to act in concert....

Abstract: Against a backdrop of emerging and reemerging infectious diseases of natural origin, fueled by changes in land use and global climate, there is an ongoing revolution in the life sciences...

Abstract: DNA synthesis providers form the primary biosecurity safety net for the synthetic biology industry.

Abstract: Industry, medical centers, academics and patient advocates have come together to create common standards for the representation and exchange of genomics information for both research and...

Abstract: Technological and social forces are allowing the growth of science outside a professionalized context.  The Internet, mobile devices, and public availability of big data are technological...

Abstract: The threat of biological attack on the people of the United States and the world, whether intentional, natural or accidental, is of growing concern, both in spite of and because of...

About the topic: Products developed using recombinant DNA methods account for over $300 billion in annual U.S.

From the 1950s through the 1970s, the success of antibiotics and vaccines in controlling or eradicating infectious diseases (ID) worldwide resulted in decreased emphasis on development of ID...

Abstract:   Bangladesh is one of the highest risk settings for emergence of new strains of influenza.

The life sciences have many examples of where research results and technologies can be used for good, but also for bad purposes.

Robert Glass, Jr. is the 2011-2012 Perry Fellow at CISAC.